Advanced search
1 file | 521.62 KB Add to list

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

SYLVIE DE BRUYNE (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , Liesbeth Ferdinande (UGent) , Wim Ceelen (UGent) , Jeroen Mertens (UGent) , Christophe Van De Wiele (UGent) , Roberto Troisi (UGent) , Louis Libbrecht (UGent) , Stéphanie Laurent (UGent) , et al.
(2012) BRITISH JOURNAL OF CANCER. 106(12). p.1926-1933
Author
Organization
Keywords
liver metastases, HEPATIC METASTASES, POSITRON-EMISSION-TOMOGRAPHY, PHARMACOKINETIC ANALYSIS, ANGIOGENESIS INHIBITOR, SYSTEMIC CHEMOTHERAPY, PERIOPERATIVE CHEMOTHERAPY, SOLID TUMORS, F-18-FDG PET, immunohistochemistry, 2-STAGE HEPATECTOMY, bevacizumab, FDG-PET/CT, colorectal cancer, DCE-MRI, PLUS IRINOTECAN

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 521.62 KB

Citation

Please use this url to cite or link to this publication:

MLA
DE BRUYNE, SYLVIE, Nancy Van Damme, Peter Smeets, et al. “Value of DCE-MRI and FDG-PET/CT in the Prediction of Response to Preoperative Chemotherapy with Bevacizumab for Colorectal Liver Metastases.” BRITISH JOURNAL OF CANCER 106.12 (2012): 1926–1933. Print.
APA
DE BRUYNE, S., Van Damme, N., Smeets, P., Ferdinande, L., Ceelen, W., Mertens, J., Van De Wiele, C., et al. (2012). Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. BRITISH JOURNAL OF CANCER, 106(12), 1926–1933.
Chicago author-date
DE BRUYNE, SYLVIE, Nancy Van Damme, Peter Smeets, Liesbeth Ferdinande, Wim Ceelen, Jeroen Mertens, Christophe Van De Wiele, et al. 2012. “Value of DCE-MRI and FDG-PET/CT in the Prediction of Response to Preoperative Chemotherapy with Bevacizumab for Colorectal Liver Metastases.” British Journal of Cancer 106 (12): 1926–1933.
Chicago author-date (all authors)
DE BRUYNE, SYLVIE, Nancy Van Damme, Peter Smeets, Liesbeth Ferdinande, Wim Ceelen, Jeroen Mertens, Christophe Van De Wiele, Roberto Troisi, Louis Libbrecht, Stéphanie Laurent, Karen Geboes, and Marc Peeters. 2012. “Value of DCE-MRI and FDG-PET/CT in the Prediction of Response to Preoperative Chemotherapy with Bevacizumab for Colorectal Liver Metastases.” British Journal of Cancer 106 (12): 1926–1933.
Vancouver
1.
DE BRUYNE S, Van Damme N, Smeets P, Ferdinande L, Ceelen W, Mertens J, et al. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. BRITISH JOURNAL OF CANCER. 2012;106(12):1926–33.
IEEE
[1]
S. DE BRUYNE et al., “Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases,” BRITISH JOURNAL OF CANCER, vol. 106, no. 12, pp. 1926–1933, 2012.
@article{3079953,
  author       = {DE BRUYNE, SYLVIE and Van Damme, Nancy and Smeets, Peter and Ferdinande, Liesbeth and Ceelen, Wim and Mertens, Jeroen and Van De Wiele, Christophe and Troisi, Roberto and Libbrecht, Louis and Laurent, Stéphanie and Geboes, Karen and Peeters, Marc},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  keywords     = {liver metastases,HEPATIC METASTASES,POSITRON-EMISSION-TOMOGRAPHY,PHARMACOKINETIC ANALYSIS,ANGIOGENESIS INHIBITOR,SYSTEMIC CHEMOTHERAPY,PERIOPERATIVE CHEMOTHERAPY,SOLID TUMORS,F-18-FDG PET,immunohistochemistry,2-STAGE HEPATECTOMY,bevacizumab,FDG-PET/CT,colorectal cancer,DCE-MRI,PLUS IRINOTECAN},
  language     = {eng},
  number       = {12},
  pages        = {1926--1933},
  title        = {Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases},
  url          = {http://dx.doi.org/10.1038/bjc.2012.184},
  volume       = {106},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: